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he epiblast of the chick embryo gives rise to the ecto-
derm, mesoderm, and endoderm during gastrulation.
Previous studies revealed that MyoD-positive cells
were present throughout the epiblast, suggesting that skeletal
muscle precursors would become incorporated into all
three germ layers. The focus of the present study was to
examine a variety of organs from the chicken fetus for the
presence of myogenic cells. RT-PCR and in situ hybridizations
demonstrated that MyoD-positive cells were present in the
brain, lung, intestine, kidney, spleen, heart, and liver. When
these organs were dissociated and placed in culture, a sub-
T
 
population of cells differentiated into skeletal muscle. The
G8 antibody was used to label those cells that expressed
MyoD in vivo and to follow their fate in vitro. Most, if not
all, of the muscle that formed in culture arose from cells
that expressed MyoD and G8 in vivo. Practically all of the
G8-positive cells from the intestine differentiated after puri-
 
ﬁcation by FACS
 
®
 
. This population of ectopically located
cells appears to be distinct from multipotential stem cells
and myoﬁbroblasts. They closely resemble quiescent,
stably programmed skeletal myoblasts with the capacity to
differentiate when placed in a permissive environment.
 
Introduction
 
Fate map analyses demonstrate the origin and destination of
cells during development; however, they do not necessarily
reveal the potential of cells to differentiate along a particular
pathway. For example, the area opaca of the chick embryo
that normally forms the extraembryonic mesoderm can be
induced to differentiate into neural tissue when Hensen’s
node is ectopically placed in this region (for review see
Storey et al., 1992). In this case, it was assumed that cells of
the area opaca were multipotential and could be induced to
change fates by factors released from Hensen’s node.
The dissociation of developmental potential from location
also has been demonstrated in studies of the myogenic
lineage. Most skeletal muscles are formed from cells derived
from the embryonic somites (for review see Christ and
Ordahl, 1995). Somites arise during gastrulation when cells
of the epiblast layer ingress through the primitive streak to
form the mesoderm (Bellairs, 1986). The region of the epi-
blast surrounding the rostral end of the primitive streak con-
tains those cells that will become incorporated into the
somites (Rosenquist, 1966). Although this region of the
epiblast is fated to form muscle, a small number of cells
expressing the skeletal muscle–specific transcription factor
MyoD are present throughout the epiblast, mesoderm, and
endoderm (Gerhart et al., 2000). Myf-5, a member of the
MyoD family, was also detected in the nonmyogenic meso-
derm (Kiefer and Hauschka, 2001). Furthermore, skeletal
muscle develops in cultures prepared from different regions
of the epiblast (George-Weinstein et al., 1996). These re-
sults led to the hypothesis that cells with the potential to dif-
ferentiate into skeletal muscle would become incorporated
into fetal organs derived from all three germ layers, but
would remain as precursors in a nonpermissive environ-
ment.
The notion that skeletal muscle precursors would come to
lie in ectopic locations after gastrulation is supported by the
fact that MyoD-positive cells were found later in develop-
ment in tissues of the chick embryo that do not give rise to
skeletal muscle, including the neural tube (Gerhart et al.,
2000). MyoD and Myf-5 mRNAs were detected in the
chondrogenic region of the somite called the sclerotome
(Gerhart et al., 2000; Kiefer and Hauschka, 2001). Myf-5
expression also was observed in the brain and spinal cord of
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mouse embryos in which the lacZ reporter gene was targeted
into the myf-5 locus (Tajbakhsh et al., 1994). Brain cells
from these animals transiently coexpress neuronal and mus-
cle proteins suggesting that they are at least bipotential.
Cells with myogenic potential are also present in non-
skeletal muscle tissues of the adult. Myofibroblasts derived
from the kidney (BHK/mesangial cells) and liver stellate
cells synthesize skeletal muscle contractile proteins when
placed in culture, although they do not assemble sarco-
meres or fuse to form multinucleated myotubes (Mayer
and Leinwand, 1997). Smooth muscle cells can convert to
skeletal muscle in vivo and in vitro (Volpe et al., 1993;
Patapoutian et al., 1995; Borirakchanyavat et al., 1997;
Link and Nishi, 1998; Graves and Yablonka-Reuveni,
2000). Dermal fibroblasts and stem cells from the bone
marrow and brain fuse with existing myofibers in vivo
(Gibson et al., 1995; Ferrari et al., 1998; Bittner et al.,
1999; Gussoni et al., 1999; Galli et al., 2000). Whereas fi-
broblasts and smooth muscle cells undergo transdifferenti-
ation, bone marrow and neuronal stem cells appear to be
multipotential. These cells have not been reported to ex-
press myogenic transcription factors before their conver-
sion to muscle. For this reason they are considered less
mature than myoblasts, the immediate precursors to dif-
ferentiated myocytes that fuse to form myofibers (Miller et
al., 1999; Cossu and Mavilio, 2000; Seale and Rudnicki,
2000).
Based on the prediction that cells expressing MyoD in
the embryonic epiblast would be incorporated into tissues
derived from all three germ layers, we have searched for
myogenic cells in a variety of mature organs from the
chicken fetus by reverse transcription (RT)*-PCR, in situ
hybridization, cell culture analyses, and FACS
 
®
 
. A small
number of MyoD-positive cells were found in seven fully
differentiated organs in vivo. Each of these organs gave
rise to skeletal muscle in vitro. When cells with MyoD
were purified from the intestine, 
 
 
 
90% formed skeletal
muscle. These results demonstrate that cells resembling
stably programmed skeletal myoblasts are ectopically lo-
cated in the fetus and are capable of differentiating in a
permissive environment.
 
Results
 
Analysis of MyoD expression by RT-PCR
 
RT-PCR was performed on 13 different fetal organs (Fig. 1).
MyoD was detected in extracts from all of these organs except
the lens and liver. When the intensity of the MyoD bands was
compared with that of GAPDH by scanning densitometry,
adipose tissue, spinal cord, skin, brain, and lung appeared to
contain relatively greater amounts of MyoD mRNA than the
heart, spleen, tendon, intestine, and kidney, but less than that
present in pectoralis skeletal muscle. Eight organs were ana-
lyzed for the expression of myogenin and sarcomeric myosin
heavy chain (Fig. 1). Only pectoralis muscle and the heart
contained detectable amounts of sarcomeric myosin mRNA.
Myogenin was found only in pectoralis muscle.
 
Localization of MyoD mRNA in fetal organs
 
Fluorescently labeled DNA dendrimers were used to localize
MyoD mRNA in sections from seven different organs. Previ-
ous experiments demonstrated that dendrimers were sensitive
and precise reagents for detecting low levels of mRNA and/or
small numbers of expressing cells by in situ hybridization
(Gerhart et al., 2000). Consistent with the results obtained
by RT-PCR, MyoD-positive cells were detected in all 7 or-
gans (Fig. 2). All sections from the kidney, heart, intestine,
and brain, and 13 out of 15 sections from the lung contained
labeled cells. The kidney, heart, lung, and intestine sections
had 1–3 cells labeled with 
 
 
 
5 dendrimers, and 5–10 other
cells with 1 or 2 dendrimers. In the intestine, the most abun-
dantly labeled cells were located in the muscularis externa
and the weakly labeled cells were present in the submucosa.
In the kidney and heart, the intensely fluorescent cells were
located in the tubules and myocardium, respectively. A thor-
ough analysis of the distribution of MyoD expression in the
brain will be conducted in a separate study; however, the op-
tic tectum contained relatively intense labeling, as did small
groups of cells in other cortical regions. Five out of nine sec-
tions from the spleen contained MyoD-positive cells that
were, for the most part, weakly labeled, although half of these
sections contained a single brightly fluorescent cell. The few-
est number of MyoD-expressing cells was found in sections
of the liver. Only 2 out of 15 sections contained one cell with
 
 
 
3 dendrimers. By contrast, pectoralis muscle tissue was
abundantly labeled with MyoD dendrimers (Fig. 2c).
Dendrimers with a recognition sequence for embryonic
fast myosin bound to cells of the heart, whereas the other or-
gans contained only 0–2 myosin dendrimers over the entire
section (Fig. 2 P). A similar level of background fluorescence
was obtained with dendrimers lacking a specific recognition
sequence. This, and the fact that myosin and myogenin
mRNAs were not detected by RT-PCR, suggest that the
MyoD-positive cells were undifferentiated.
 
*Abbreviations used in this paper: GAPDH, glyceraldehyde-3-phosphate
dehydrogenase;
 
 
 
RT, reverse transcription.
Figure 1.  RT-PCR analysis of MyoD expression in fetal organs. 
mRNA from fetal organs was incubated with primers for MyoD, 
embryonic fast myosin (MHC), myogenin (MG), or GAPDH in the 
presence ( ) or absence ( ) of reverse transcriptase. MyoD (263 bp) 
was detected in all samples except the liver and lens. Myosin (616 
bp) was expressed in pectoralis muscle and the heart. Myogenin 
(278 bp) was only detected in pectoralis muscle. 
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Determination of whether MyoD mRNA was translated
into protein was carried out by fixing cells immediately after
organ dissociation and centrifuging them onto slides. This
was done because the antibody to MyoD protein did not la-
bel pectoralis muscle cells after embedding in paraffin.
MyoD protein was not detected in cells from the intestine,
kidney, heart, liver, lung, and brain (unpublished data).
 
Myogenesis in cultures prepared from fetal organs
 
The ability of cells from fetal organs to undergo skeletal
myogenesis was tested by culturing them under conditions
previously designed to support the differentiation of embry-
onic epiblast and paraxial mesoderm cells (George-Wein-
stein et al., 1994, 1996). When plated on a substrate of gela-
tin and fibronectin, 
 
 
 
90% of cells from all of the organs
Figure 2.  Localization of MyoD mRNA 
in fetal organs. In situ hybridizations 
were performed on sections of fetal 
organs. Low magnification images of the 
sections are shown to the left of each 
series. Fluorescence photomicrographs 
are the merged images of dendrimers in 
red and bis-benzamide labeled nuclei in 
blue. A few MyoD-positive cells were 
found in sections through each organ 
(arrows). Erythrocytes were autofluores-
cent (arrowheads). Pectoralis muscle 
was abundantly labeled with MyoD 
dendrimers (O). Dendrimers to myosin 
(P) did not label these sections. Bar, 135 
 m in the fluorescence photomicro-
graphs; 9  m in the bright field images.
 
Table I. 
 
Myogenesis in fetal organ cultures
 % Muscle: 2 d  % Skeletal muscle: 2 d % Multinucleated myotubes: 10 d
 
Intestine 15 
 
 
 
 3 (10) 16 
 
 
 
 3 (9) 45 
 
 
 
 6 (6)
Kidney 17 
 
  
 
8 (8) 15 
 
 
 
 7 (13) 52 
 
 
 
 4 (8)
Lung 12 
 
 
 
 6 (15) 17 
 
 
 
 6 (7) 35 
 
 
 
 2 (8)
Spleen 9 
 
 
 
 4 (8) 9 
 
 
 
 5 (8) 35 
 
 
 
 4 (9)
Liver 2 
 
 
 
 1 (12)
 
 
 
1 43 
 
 
 
 6 (8)
Heart 86 
 
 
 
 10 (6) 17 
 
 
 
 10 (8) 46 
 
 
 
 4 (4)
Cells were fixed after 2 or 10 d in culture and stained with the MF20 antibody to sarcomeric myosin (Muscle) and the 12101 or skeletal troponin T antibodies
(Skeletal muscle). The percentage of muscle and the percentage of skeletal muscle 
 
  
 
number of MF20, 12101, or skeletal troponin T cells/total number of
cells 
 
 
 
 100. The percentage of muscle cells that formed multinucleated myotubes 
 
  
 
number of nuclei in MF20 or 12101 positive multinucleated cells/total
number of nuclei in MF20 and 12101 positive multinucleated and single nucleated cells 
 
  
 
100. The number of cultures scored is indicated in parentheses.
A minimum of 200 cells were scored per culture. Results are the mean 
 
 
 
 SD. 
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Figure 3.  Myogenesis in cultures of 
cells prepared from fetal organs. Fetal 
organs were dissociated and the cells 
plated at high density. Cells were stained 
with the skeletal muscle specific 12101 
(A–C, E and F) or troponin T (D) 
antibody, and an antibody to α-actinin 
(G and H). Striations can be seen in A 
and H (arrows). Multinucleated 
myotubes are shown in B and D–F. 
Bar, 9  m.
 
except the brain attached to the dish. The plating efficiency
for brain cells was 
 
 
 
5%, reflecting less than optimal culture
conditions. Therefore, only qualitative analyses were per-
formed with cultures of brain cells.
Cells were stained with antibodies to sarcomeric myosin,
 
 
 
-actinin, and the skeletal muscle–specific 12101 antigen
and troponin T (Fig. 3 and Table I). The specificity of the
12101 and troponin T antibodies was tested in cryosections
of days 10 and 11 chick embryo pectoralis muscle and heart.
Abundant staining was observed in pectoralis muscle,
whereas neither antibody labeled cardiac muscle.
All of the organs gave rise to varying amounts of skeletal
muscle (Table I and Fig. 3). The percentage of muscle cells
began to decline after 48 h (unpublished data), presumably
due to the continued growth of nonmuscle cell types. Consis-
tent with the RT-PCR and in situ hybridization results, very
few muscle cells were observed in cultures of liver cells. The
spleen produced more muscle than would have been expected
from the other types of analyses. In some cells, a striated pat-
tern was observed after staining with the myosin, 12101, and
 
 
 
-actinin antibodies suggesting sarcomere formation (Fig. 3).
Multinucleated myotubes were observed in older cultures 
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(Figure 3 and Table I). The percentage of myotubes was rela-
tively high considering the heterogeneity of the cultures.
 
Analysis of the potential of MyoD-positive cells to 
differentiate into skeletal muscle
 
Two methods were employed to determine whether the cells
that formed muscle in culture arose from those that express
MyoD in vivo. In both types of experiments, the G8 mono-
clonal antibody was used to mark the MyoD-positive cells.
This antibody was generated by immunizing mice with
somite and segmental plate mesoderm cells from stages 12–
14 embryos. Details of the pattern of expression of the G8
antigen during embryogenesis will be presented elsewhere.
In brief, G8 binds to myoblasts and myotubes in pectoralis
muscle cultures, a subpopulation of segmental plate cells and
the dermomyotome in vivo, and colocalizes with MyoD
dendrimers in the epiblast.
Double label experiments were performed to test whether
the G8 antibody would bind to cells that express MyoD
mRNA in fetal organs. Most cells that expressed MyoD were
labeled with the G8 antibody in sections from the intestine,
kidney, heart, lung, spleen, and liver (Fig. 4). A few cells
with weak labeling for MyoD did not stain with G8. This
may be due to the fact that the antigen was below the level
of detection with antibody or that the cells were sectioned,
as MyoD protein was detected in 100% of the G8-positive
cells in culture (see below).
The G8 antibody was used to mark living cells that ex-
press MyoD. Organs were dissociated, labeled in suspension
with G8, and then placed in culture. Cells were stained with
an IgM-specific secondary antibody conjugated with Alexa
488 to tag G8, the MF20 IgG antibody to sarcomeric myo-
sin, and an IgG specific secondary antibody conjugated with
rhodamine. All G8-positive cells contained MyoD protein,
and all cells with MyoD were stained for G8 (Fig. 5, A, D,
 
Table II. 
 
Differentiation of G8-positive cells in vitro
% G8-positive
 
 
 
cells with myosin
% Myosin-positive 
cells with G8
 
Intestine 92 
 
 
 
 3 (8) 93 
 
 
 
 4 (8)
Kidney 42 
 
 
 
 9(4) 90 
 
 
 
 3 (4)
Spleen 31 
 
 
 
 7 (4) 94 
 
 
 
 5 (4)
Lung 46 
 
 
 
 9 (10) 92 
 
 
 
 5 (10)
Heart 90 
 
 
 
 7 (4) 28 
 
 
 
 4 (4)
Liver 43 
 
 
 
 8 (7) 100 (7)
Cells were prelabeled with G8, cultured for 48 h, and stained with
fluorescent antibodies to IgM, the MF20 antibody to sarcomeric myosin,
and fluorescent antibodies to IgG. The percentage of G8-positive cells with
myosin 
 
 
 
 cells positive for both G8 and myosin/total number of G8-
positive cells 
 
 
 
 100. The percentage of myosin-positive cells with G8  
 
 
 
cells positive for both molecules/total number of myosin-positive cells 
 
 
 
100. The number of cultures scored is indicated in parentheses. A minimum
of 200 cells were scored per culture. Results are the mean 
 
  
 
SD.
Figure 4.  Colocalization of the G8 
antigen with MyoD mRNA in vivo. 
Sections were labeled with the G8 
antibody and a secondary antibody 
conjugated with Alexa 488 (green). In 
situ hybridization was then performed 
with MyoD dendrimers (red). G8 
colocalized with MyoD in most cells. 
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E, and G). Most of the G8-positive cells (
 
 
 
95%) also ex-
pressed Myf5 protein, and all cells with Myf5 had G8 (Fig.
5, B and C).
Some of the cells that had bound G8 directly after removal
from the fetus differentiated into skeletal muscle (Table II and
Fig. 5, F and H). Approximately 90% of the myosin positive
cells that formed from all organs except the heart were also
positive for G8, suggesting that most, if not all, of the differ-
entiated muscle arose from cells that expressed MyoD in vivo.
The low percentage of myosin-positive cells with G8 in heart
cultures was expected because the MF20 antibody recognizes
the myosin heavy chain in both skeletal and cardiac muscle.
Because the intensity of G8 fluorescence varied from cell
to cell, it was possible that some cells lost the G8 signal as a
result of metabolism or dilution from replication. Intestine
cultures were labeled with BrdU to determine whether cells
with G8 were capable of proliferating. After 4 h of incuba-
tion in BrdU, 11 
 
 
 
 5% (
 
n
 
 
 
 
 
 8) of the intestine cells that
bound G8 were determined to be in the S phase of the cell
cycle (Fig. 5 I).
 
Analysis of the expression of nonskeletal muscle 
proteins in G8-positive cells
 
Cells from the heart and brain with the potential to differen-
tiate into skeletal muscle were examined for the presence of
cardiac muscle–specific troponin I and neurofilament pro-
tein, respectively. Because cytoplasmic staining of a single
MyoD-positive cell surrounded by cardiac myocytes or neu-
Figure 5.  Immunofluorescence localization of cell type–specific proteins and BrdU in G8-positive cells in vitro. Cells from fetal organs 
were prelabeled with the G8 antibody, cultured for 48 h, and then stained with a secondary antibody to G8 and antibodies to MyoD, Myf5, 
or sarcomeric myosin. Cells from the lung, liver, kidney, and intestine that were labeled with G8 (green) had MyoD and myosin (red). Double 
labeling for G8 (red) and Myf5 (green) was seen in lung and heart cells. G8-positive intestine cells (green) incorporated BrdU (red) indicating 
replication. In a second type of experiment, cells from the heart and brain were fixed directly after removal from the fetus, centrifuged onto 
slides, and stained with G8 (red in J; green in L) and antibodies to cardiac troponin I (green) and neurofilament protein (red), respectively. 
Cells labeled with G8 did not have detectable levels of cardiac troponin (J) or neurofilament protein (L). Cells with cardiac troponin (K) and 
neurofilament protein (L) were not labeled with G8. Bar, 9  m. 
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rons would be difficult to unambiguously resolve in paraffin
sections, this experiment was carried out with freshly disso-
ciated and fixed cells centrifuged onto glass slides. The spec-
ificity of the cardiac troponin I antiserum was tested by la-
beling cryosections of pectoralis muscle and the heart. The
antiserum-stained cardiac tissue but not skeletal muscle.
None of the G8-positive cells contained detectable levels of
cardiac troponin I or neurofilament protein (Fig. 5, J and L).
These proteins were observed in cells lacking G8 (Fig. 5, K
and L). This suggests that cells that express MyoD in the heart
and brain do not synthesize cardiac or neuronal proteins.
 
Isolation of G8/MyoD-positive cells by FACS
 
®
 
FACS
 
®
 
 was used to isolate those cells that expressed MyoD
in vivo after labeling with the G8 antibody. Profiles of for-
ward light scatter, a relative measure of cell size, versus G8
fluorescence intensity, were similar for cells of the intestine,
kidney, and heart (Fig. 6). After gating for dead cells and de-
bris, the G8-positive cells were the smallest in preparations
from all three organs. The total cells labeled with the G8 an-
tibody was 
 
 
 
0.5%, or 1.2% after gating.
G8 labeled and unlabeled intestine cells were sorted and
placed in culture. Greater than 90% of the G8-positive cells
differentiated into muscle within the first 48 h in culture
(% 
 
 
 
 92 
 
 
 
 5, 
 
n
 
 
 
 
 
 9). Less than 1% of the cells in G8-neg-
ative cultures contained detectable levels of sarcomeric myo-
sin (
 
n
 
 = 10). Staining with the 12101 antibody revealed that
the muscle that formed in G8-positive cultures was skeletal
muscle (Fig. 6). These experiments suggest that the muscle
that emerged in unsorted cultures arose from cells that ex-
pressed MyoD and G8 in vivo.
 
Discussion
 
Cells that express MyoD have been found in a variety of fully
differentiated fetal organs derived from all three germ layers.
This was predicted based on the fact that MyoD-positive cells
are present in regions of the chick epiblast that give rise to the
ectoderm, medial and lateral mesoderm, and endoderm (Ger-
hart et al., 2000). Slightly later in development, a few cells
with MyoD were observed throughout the embryo, including
the neural tube. Myf5 also was detected in nonsomitic tissues
of the chick embryo (Kiefer and Hauschka, 2001), and in
transgenic mice in which the lacZ reporter gene was targeted
into the myf5 locus (Tajbakhsh et al., 1994).
Several questions arise from these findings. First, can cells
that express MyoD in ectopic locations differentiate into
skeletal muscle in the appropriate environment? The G8 an-
tibody has enabled us to test this directly, as G8 colocalizes
with MyoD in fetal organs and presumably is expressed in
the same cells. Cells that bound G8 directly after organ dis-
sociation synthesized sarcomeric myosin and the skeletal
muscle–specific 12101 antigen in vitro. The percentage of
this population that differentiated increased dramatically
when the G8-positive cells from the intestine were isolated
by FACS
 
®
 
 before placement in culture. This probably re-
flects a “community effect,” a phenomenon in which cells of
similar potential communicate with one another to promote
differentiation (Gurdon, 1988). However, in unsorted cul-
tures, some of the cells with myosin were completely sur-
rounded by nonmuscle cells, and therefore did not require
contact with other myogenic cells. These experiments dem-
onstrate that cells expressing MyoD in ectopic locations in
vivo have retained the capacity to form muscle and are
poised to do so when placed in a permissive environment.
Do the MyoD-positive cells of fetal chick organs resemble
any cell type previously identified? Myofibroblasts are
present in many organs, and under certain conditions ex-
press genes typical of smooth and/or skeletal muscle cells
(for review see Mayer and Leinwand, 1997). Sarcomeric my-
osin was detected in myofibroblast stellate cells of the liver in
vivo (Mayer and Leinwand, 1997). Cell lines derived from
liver stellate cells and myofibroblasts of the kidney called
mesangial cells express several sarcomeric proteins in vitro;
however, they do not fuse to form multinucleated myotubes
or assemble sarcomeres (Mayer and Leinwand, 1997). By
contrast, the MyoD-positive cells in fetal organs do not ex-
press sarcomeric myosin or myogenin in vivo, but do form
myotubes and appear to assemble sarcomeres in vitro. Fur-
thermore, MyoD-expressing cells were found in the tubules
of the kidney, and were not associated with renal corpuscles
where mesangial cells are located (Johnson et al., 1992).
Figure 6.  Flow cytometry and FACS
® of fetal cells. Fetal heart, 
kidney, and intestine cells were labeled with the G8 antibody and 
fluorescein-conjugated secondary antibody. Profiles of fluorescence 
intensity versus forward light scatter (cell size) were compared in 
cells labeled with G8 (green) and those labeled with the secondary 
antibody alone (red) (A–C). G8-positive (R2 population) and 
negative intestine cells (R3 population) were sorted (D), placed in 
culture for 2 d, and then stained with the 12101 antibody. Most of 
the G8-positive cells differentiated into skeletal muscle (E), whereas 
very few myosin positive cells were observed in the G8-negative 
cultures (F). Bar, 9  m. 
388 The Journal of Cell Biology 
 
|
 
 
 
Volume 155, Number 3, 2001
 
Therefore, the cells that express MyoD in organs lacking
skeletal muscle may be distinct from the myofibroblast.
MyoD-positive cells in fetal organs also appear to differ
from fibroblasts (Chaudhari et al., 1989; Gibson et al.,
1995, Salvatori et al., 1995), bone marrow cells (Wakitani et
al., 1995; Prockop, 1997; Ferrari et al., 1998; Bittner et al.,
1999; Gussoni et al., 1999), cells from the embryonic dorsal
aorta (DeAngelis et al., 1999), and neuronal stem cells (Galli
et al., 2000) that can differentiate into skeletal muscle in
vitro and fuse with myofibers in vivo. RT-PCR analyses of
the dorsal aorta and neural stem cells failed to detect the ex-
pression of myogenic transcription factors (DeAngelis et al.,
1999; Galli et al., 2000). This, and the fact that they are able
to differentiate into other cell types, has led to the conclu-
sion that they are less mature and have greater plasticity than
myoblasts that do express MyoD and Myf5.
The MyoD-positive cells located in fetal organs most re-
semble the myoblast. Both cell types express myogenic
transcription factors, replicate, and form striated myo-
tubes. Myoblasts can be considered a stem cell in that they
replicate and self-renew; however, their potential to form
other tissues has not been equivocally demonstrated. Over
two decades ago it was suggested that myoblasts may be at
least bipotential, as replicating cells from fetal muscle re-
sembling myoblasts at the ultrastructural level formed
bone when cultured on demineralized bone matrix (Na-
thanson and Hay, 1989). More recent studies demon-
strated that undifferentiated cells isolated from adult mus-
cle are heterogeneous (Schultz and Jaryszak, 1985; Barrofio
et al., 1995; Rantenen et al., 1995; Schultz, 1996; Yoshida
et al., 1998; Beauchamp et al., 1999; Lee et al., 2000), and
at least some have the capacity to undergo myogenesis, os-
teogenesis, and/or hematopoiesis (Gussoni et al., 1999;
Jackson et al., 1999; Lee et al., 2000). These cells appear to
differ from the majority of myogenic cells in adult muscle
that have limited proliferative and regenerative capacity
(Beauchamp et al., 1999). Most precursors in adult muscle
also express CD34, Myf5, and M-cadherin, and therefore,
may be committed to the myogenic lineage (Beauchamp et
al., 2000).
The MyoD-positive/myosin negative cells located in fetal
organs lacking skeletal muscle also appear to be stably com-
mitted to the myogenic lineage. This is based on several
pieces of evidence. First, most of the cells prelabeled with the
G8 antibody that differentiated in unsorted cultures were
surrounded by nonmuscle cells, thereby demonstrating in-
dependence from a community effect. Second, when the
MyoD/G8-positive cells were isolated from the intestine by
FACS
 
®
 
, practically all of them differentiated rapidly. Third,
the foreign environment in which these cells reside in vivo,
surrounded by differentiated epithelial, connective tissue, or
smooth and cardiac muscle cells, has not repressed the ex-
pression of MyoD. Lastly, in the heart and brain, the
MyoD/G8-positive cells do not appear to express cardiac
and neuronal proteins. Although obviously biased towards a
myogenic fate, it is possible that if placed in a more challeng-
ing environment, for example, in developing tissues of
younger embryos, multipotentiality would be revealed. This
experiment is now possible, as the MyoD-positive cells can
be purified by sorting the with G8 antibody.
Related to the issue of commitment is the origin of this
subpopulation of cells. Cells with MyoD have been local-
ized to regions of the epiblast that give rise to all three
germ layers of the embryo (Gerhart et al., 2000). A day
later, small numbers of cells expressing MyoD were found
outside of the somites, the source of most skeletal muscle
of the body. Preliminary studies in which the G8 antibody
was used to label epiblast cells in whole embryo culture
suggest that this population does indeed become incorpo-
rated into a variety of tissues during gastrulation. Whether
they survive until fetal stages and continue to express
MyoD remains to be determined. If fetal cells with MyoD
do originate in the epiblast, then one would expect them to
retain their myogenic identity when challenged in an em-
bryonic environment that promotes the differentiation of
nonskeletal muscle cell types.
The biological relevance of finding potentially stably pro-
grammed myoblasts in ectopic locations is a matter of specu-
lation. Although apparently quiescent in a foreign environ-
ment, it seems possible that damage to a tissue with resulting
inflammation could activate their proliferation. Another
possible scenario is that they may be vulnerable to transfor-
mation. Rhabdomyosarcomas are malignant tumors com-
prised of cells expressing skeletal muscle proteins. Interest-
ingly, the primary tumors most often are found in sites other
than skeletal muscle such as the genitourinary tracts, orbit of
the eye, and glands (for review see Dagher and Helman,
1999; Merlino and Helman, 1999). It has been postulated
that these neoplasias arise from myogenic precursor cells, al-
though their origin has not been identified. It seems possible
that those rhabdomyosarcomas histologically and genetically
characterized as embryonal tumors could arise from ectopi-
cally located myoblasts that have now been identified based
on the expression of MyoD. On a more optimistic note, re-
cent advances in the isolation of stem cells from the adult
has generated tremendous hope for the treatment of a vari-
ety of diseases. Although multipotential cells may have a
greater capacity for proliferation and self-renewal than com-
mitted cells, communication between the two is critical for
tissue development in the embryo (for review see Gurdon,
1992; Horvitz and Herskowitz, 1992; Schnabel, 1995). Im-
plantation of a mixture of these cell types may improve the
efficiency of tissue regeneration.
 
Materials and methods
 
RT-PCR
 
The following organs were removed from day 15 White Leghorn chick
fetuses: pectoralis muscle, intestine, kidney, heart, spleen, lung, brain,
spinal cord, liver, the entire eye, lens, tendon, skin, and adipose tissue.
RNA was extracted and RT-PCR performed as described previously
(George-Weinstein et al., 1996). Primer pairs for MyoD were nucle-
otides 620–639, 5
 
 
 
-CGT GAG CAG GAG GAT GCA TA-3
 
 
 
 and 864–
883, 5
 
 
 
-GGG ACA TGT GGA GTT GTC TG-3
 
  (Lin et al., 1989); glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) nucleotides 680–699,
5 -AGT CAT CCC TGA GCT GAA TG-3  and 990–1009, 5 -AGG ATC
AAG TCC ACA ACA CG-3  (Dugaiczyk et al., 1983); myogenin nucle-
otides 435–453, 5 AGC CTC AAC CAG CAG GAG C-3  and 694-713,
5 -TGC GCC AGC TCA GTT TTG GA-3  (Fujisawa-Sehara et al., 1990);
and myosin heavy chain nucleotides 392–411, 5 -GAT CCA GCT GAG
CCA TGC CA-3  and 1008–989, 5 -GCT TCT GCT CAG CAT CAA CC-
3  (Kavinsky et al., 1983). Reaction products were separated on 6%
polyacrylamide gels and Phosphorous-32 incorporation visualized by
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In situ hybridization
The intestine, kidney, heart, spleen, lung, brain, liver, and pectoralis mus-
cle were removed from day 17 chick fetuses, fixed in 4% formaldehyde for
18 h, and embedded in paraffin. 10-mm sections were applied to teflon
printed slides (Electron Microscopy Sciences) coated with 0.2% gelatin.
The in situ hybridization procedure was carried out with 3DNA Starfish™
reagents, as described in Gerhart et al. (2000). In brief, tissues were perme-
abilized in Triton X-100 and pepsin. Sections were incubated in buffer
containing Cy3 labeled DNA dendrimers (Nilsen et al., 1997; Vogelbacker
et al., 1997; Wang et al., 1998) to which cDNA sequences for specific
mRNAs plus 7 bases complementary to the dendrimer had been ligated to
the outer dendrimer arms (Genisphere, Inc.). The dendrimers contained
the following antisense sequences for mRNAs: chicken MyoD (Dechesne
et al., 1994), 5 -TTC TCA AGA GCA AAT ACT CAC CAT TTG GTG ATT
CCG TGT AGT AGC TGC TG-3 ; chicken embryonic fast myosin (Freyer
and Robbins, 1983), 5 -CAG GAG GTG CTG CAG GTC CTT CAC CGT
CTG GTC CAG GTT CTT CTT CAT CCT CTC TCC AGG-3 ; and chicken
GAPDH (Dugaiczyk et al., 1983), 5 -ATC AAG TCC ACA ACA CGG TTG
CTG TAT CCA AAC TCA TTG TCA TAC CAG GAA-3 . Dendrimers lacking
a specific recognition sequence were used as a negative control for back-
ground fluorescence. Nuclei were counterstained with bis-benzamide.
Sections were observed with a Nikon Eclipse E800 epifluorescence micro-
scope and photomicrogaphs produced with the Optronics DEI 750 video
camera and Image-Pro Plus image analysis software (Phase 3 Imaging Sys-
tems).
The following number of in situ hybridizations were performed with
MyoD dendrimers: 15 intestine sections from 3 fetuses, 27 kidney sections
from 5 fetuses, 24 heart sections from 5 fetuses, 15 lung sections from 3 fe-
tuses, 9 spleen sections from 2 fetuses, 15 liver sections from 3 fetuses, and
5 brain sections from 1 fetus.
Cell culture
Organs from day 17 fetuses were incubated in 0.25% trypsin-EDTA for 10–
20 min and passed through an 18–22-gauge needle to dissociate the tissues.
Cells were cultured under conditions that were previously determined to
promote the differentiation of embryonic epiblast and paraxial mesoderm
cells (George-Weinstein et al., 1994, 1996). Twenty thousand cells in 15  l
of DME containing 5% fetal bovine serum, 5% horse serum, 5% chick em-
bryo extract, and 100 units of penicillin and streptomycin (myo medium)
were plated onto tissue culture dishes coated with gelatin and human serum
fibronectin (GIBCO/BRL). Dishes were flooded with 1.5 ml serum and hor-
mone-free DME/F12 medium (GIBCO/BRL) 45 min after plating.
Generation of the G8 monoclonal antibody
The G8 monoclonal antibody was generated by immunizing female BALB/c
mice three times with 10
6 cells from the posterior 12 pairs of somites and
the segmental plate mesoderm cells from stages 12–14 embryos (Ham-
burger and Hamilton, 1951). Cells were fixed in 2% formaldehyde before
intraperitoneal injection. Immune lymphocytes were fused with SP2/0-
AG14 myeloma cells and plated in HAT selection media (Kohler and Mil-
stein, 1976). Monoclonal antibody–producing clones were selected based
on their immunoreactivity against cryosections from stage 14 embryos. Hy-
bridomas producing antibodies that bound to subpopulations of cells were
cloned and retested for reactivity in cryosections. Antibody subclass char-
acterization was determined using the MonoAb ID-mouse kit (Zymed). The
G8 monoclonal antibody was determined to be an IgM, kappa. Ascites fluid
was produced by the method of Hoogenraad et al. (1983), treated with 5%
sodium dextran sulfate and 11.1% calcium choloride to remove lipopro-
teins (Walton and Scott, 1964), immunoglobulin precipitated by 50% satu-
ration with ammonium sulfate, dialyzed against calcium and magnesium-
free Dulbecco’s PBS, and filter sterilized. Immunizations, fusion, subcloning,
subclass determination, and production of ascites fluid were carried out in
the University of Illinois’ Hybridoma Laboratory in the Biotechnology/Cell
Science Center (Urbana, IL). The antigenic determinant of the G8 antibody
has yet to be identified and characterized.
Immunofluorescence localization
Cells were fixed in 2% formaldehyde, permeabilized with 0.5% Triton
X-100, and labeled with primary and fluorescent secondary antibodies as
described previously (George-Weinstein et al., 1994). The MF20 mono-
clonal antibody to myosin heavy chain (Bader et al., 1982), the skeletal
muscle specific 12101 monoclonal antibody (Kitner and Brockes, 1984),
and the 2H3 monoclonal antibody to neurofilament protein (Dodd et al.,
1988) were obtained from the Developmental Studies Hybridoma Bank,
Iowa City, IA. The F5D3 monoclonal antibody to skeletal muscle specific
troponin T (Shimizu and Shimada, 1985) and polyclonal rabbit antiserum
to cardiac muscle specific troponin I (Toyota and Shimada, 1981) were
gifts from Dr. N. Toyota (Chiba University, Chiba, Japan). Monoclonal an-
tibodies  -actinin (A7811) and MyoD (NCL-MyoD1) were purchased from
Sigma-Aldrich and Novocastra Labs., respectively. Myf5 polyclonal antise-
rum was supplied by Dr. Bruce Paterson (National Institutes of Health, Be-
thesda, MD). Secondary antibodies were affinity-purified, goat anti–mouse
or anti–rabbit F(ab )2 fragments conjugated with rhodamine, Cy3, or fluo-
rescein (Jackson ImmunoResearch Laboratories). Nuclei were counter-
stained with bis-benzamide.
Double labeling with the G8 antibody and MyoD dendrimers was car-
ried out in paraffin sections of day 17 fetal organs. The antibody was ap-
plied first, followed by a goat anti–mouse IgM secondary antibody con-
jugated with Alexa 488 (Molecular Probes). In situ hybridization with
Cy3-labeled MyoD dendrimers then was performed as described above.
Nuclei were counterstained with bis-benzamide.
The G8 antibody was used to label living cells that expressed MyoD and
to determine whether those cells could differentiate into skeletal muscle in
vitro. Organs were dissociated in 0.25% trypsin-EDTA, centrifuged, and re-
suspended in myo medium. Cells were incubated in G8 diluted 1:40 for
1 h, centrifuged, and resuspended in myo medium. Cells were plated as
described above and fixed 24 or 48 h later. G8 was labeled with the IgM-
specific secondary antibody conjugated with Alexa 488, MF20 IgG, and an
IgG specific secondary antibody conjugated with rhodamine (Chemicon).
Determination of whether cells that expressed the G8 antigen in vivo
contained MyoD protein was carried out by dissociating organs directly af-
ter their removal from the fetus, fixing cells as described above, then cen-
trifuging them onto gelatin-coated glass slides. Cells were stained with the
G8 antibody, the anti-IgM antibody conjugated with Alexa 488, the anti-
body to MyoD, and anti–mouse IgGs conjugated with Cy3. This procedure
was also used to analyze G8-positive cells from the heart and brain for the
expression of cardiac troponin I and neurofilament protein, respectively.
Analysis of replication of G8-positive cells
Intestine cells were prelabeled with the G8 antibody and placed in culture
as described above. 10  M bromodeoxyuridine (BrdU) was added to the
medium the day after plating. 4 h later the cells were rinsed, fixed, and
stained with the IgM-specific secondary antibody conjugated with Alexa
488 to label G8, an IgG to BrdU (Roche Diagnostics), and rhodamine-con-
jugated anti-IgGs. Nuclei were counterstained with bis-benzamide.
Flow cytometry and FACS
®
Day 17 intestines, kidneys, and hearts were dissociated as described above
and divided into three aliquots. One aliquot was incubated with the G8
antibody diluted 1:20–1:40 for 1 h at 37 C, centrifuged, and resuspended
in myo medium containing goat anti–mouse IgM antibodies conjugated
with fluorescein for 1 h at 37 C. The second aliquot of cells was incubated
with only secondary antibody (control for background fluorescence) and
the third aliquot received no antibodies (control for autofluorescence).
Cells were centrifuged, resuspended in PBS containing 0.5% bovine serum
albumin and 100 units of penicillin and streptopmycin, and filtered
through a cell strainer (Falcon). Profiles of fluorescence intensity, forward
light scatter, and side scatter were obtained with the FACStar Plus cell
sorter (Becton Dickinson). After gating to eliminate dead cells and debris,
G8-positive and negative intestine cells were sorted. Cells were placed in
culture, fixed after 48 h, and stained with the MF20 and 12101 antibodies
and IgG-specific secondary antibody conjugated with rhodamine. Cell
sorting was carried out at the University of Pennsylvania’s Flow Cytometry
and Cell Sorting Shared Resources Facility (Philadelphia, PA). Analyses of
fluorescence intensity and forward light scatter were consistent in eight ex-
periments. Cell sorting results were from three different experiments. Mul-
tiple cultures were prepared with the positive and negative cells from each
experiment.
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